Table 3 Patient characteristics, risk factors, and clinical data according to the presence or absence of postimplantation syndrome (PIS) after endovascular aortic repair (EVAR)
PIS, n = 8 | Non-PIS, n = 26 | P | |
|---|---|---|---|
Age, years | 78.8 ± 8.5 | 74.8 ± 8.4 | 0.25 |
Male gender, n (%) | 6 (75) | 19 (73) | 1.00 |
HTN, n (%) | 5 (63) | 20 (77) | 0.65 |
DM, n (%) | 1 (13) | 4 (15) | 1.00 |
CAOD, n (%) | 1 (13) | 5 (19) | 1.00 |
CVA, n (%) | 1 (13) | 6 (23) | 1.00 |
CRF, n (%) | 0 (0) | 2 (8) | 1.00 |
Antiplatelet agent, n (%) | 4 (50) | 15 (58) | 1.00 |
Statin, n (%) | 2 (25) | 14 (54) | 0.23 |
Mural thrombus, ml | 64.8 ± 50.2 | 81.6 ± 69.1 | 0.53 |
Fresh thrombus, ml | 65.8 ± 56.5 | 35.7 ± 34.1 | 0.19 |
Gas formation, n (%) | 5 (63) | 12 (46) | 0.69 |
Fever, n (%) | 8 (100) | 3 (12) | < 0.01 |
WBC, ×103/μl | 17.1 ± 3.6 | 12.7 ± 4.5 | 0.02 |
PLT, ×103/μl | 258.4 ± 64.4 | 217.2 ± 63.4 | 0.12 |
CRP, mg/dL | 12.7 ± 3.1 | 10.4 ± 7.0 | 0.22 |
ESR, mm/h | 84.8 ± 25.4 | 69.3 ± 28.8 | 0.29 |
ICU stay, hours | 25.0 ± 17.1 | 21.6 ± 13.5 | 0.57 |
Hospital stay, days | 10.8 ± 6.3 | 9.6 ± 14.0 | 0.82 |